Stock BGLC BIONEXUS GENE LAB CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases BioNexus Gene Lab Corp.

Equities

BGLC

US0906282076

Market Closed - Nasdaq
Other stock markets
 21:30:00 14/05/2024 BST 		5-day change 1st Jan Change
0.5829 USD +0.48% Intraday chart for BioNexus Gene Lab Corp. -2.56% +9.98%
04-16 BioNexus Gene Lab Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
02-29 BioNexus Gene Lab Corp. Provides Information to Shareholders CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare
AQ
BioNexus Gene Lab : Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare - Form 8-K
PU
BioNexus Gene Lab : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market
AQ
BioNexus Gene Lab : Modification to Rights of Security Holders - Form 8-K
PU
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
AQ
BIONEXUS GENE LAB CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
BIONEXUS GENE LAB CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
BIONEXUS GENE LAB CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
BIONEXUS GENE LAB CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
BIONEXUS GENE LAB CORP : Change in Directors or Principal Officers (form 8-K)
AQ
BIONEXUS GENE LAB CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
BIONEXUS GENE LAB CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
BIONEXUS GENE LAB CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
BIONEXUS GENE LAB : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
BIONEXUS GENE LAB : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
BIOS GENE : BIONEXUS GENE LAB CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
BIONEXUS GENE LAB : Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits (form 8-K/A)
AQ
BIONEXUS GENE LAB CORP : Financial Statements and Exhibits (form 8-K)
AQ
BIONEXUS GENE LAB CORP : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BGLC Stock
  4. News BioNexus Gene Lab Corp.
  5. Press Releases